Facebook Twitter LinkedIn Google Plus RSS

Catalent Pharma, in Somerset, registers for IPO

By ,

Somerset-based Catalent Pharma Solutions announced Friday its parent company Catalent Inc. has registered with the Securities and Exchange Commission for an initial public offering.

According to the announcement, the number of shares to be offered and the price range for the proposed offering have not yet been determined. The company intends to use the net proceeds from the offering to repay debt, with any remaining balance to be used for general corporate purposes.

Submit a nomination for General Counsel of the Year >

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy